scispace - formally typeset
H

Hadwiga Nowotny

Researcher at University of Vienna

Publications -  12
Citations -  662

Hadwiga Nowotny is an academic researcher from University of Vienna. The author has contributed to research in topics: Cytogenetics & Myelodysplastic syndromes. The author has an hindex of 7, co-authored 12 publications receiving 654 citations.

Papers
More filters
Journal Article

Multiple Myeloma: High Incidence of Chromosomal Aneuploidy as Detected by Interphase Fluorescence in Situ Hybridization

TL;DR: Interphase FISH, by which chromosomal aneuploidy was detected in almost 90% of patients with MM, represents an approach for evaluating the clinical significance of specific chromosomal abnormalities in MM.
Journal ArticleDOI

Myelodysplastic syndromes, from French-American-British to World Health Organization: comparison of classifications on 431 unselected patients from a single institution.

TL;DR: These data cannot provide evidence for the new WHO proposal for myelodysplastic syndromes classification and should not be adopted for routine clinical use at present, but can provide a starting point for further studies involving refined cytogenetics and clinical results.
Journal ArticleDOI

Cross‐validation of prognostic scores in myelodysplastic syndromes on 386 patients from a single institution confirms importance of cytogenetics

TL;DR: Cytogenetic scores significantly improved the prognostic value of the best clinical/morphological score in regard to both overall survival and preleukaemic duration, and further stress the importance of cytogenetics for predicting prognosis in MDS.
Journal ArticleDOI

Clinicopathogenetic Significance of Chromosomal Abnormalities in Patients With Blastic Peripheral B-Cell Lymphoma

TL;DR: The findings underline that Burkitt's, cb, ib, and blastoid mantle-cell lymphoma are biologically distinct and clinically relevant entities and that cytogenetic findings can be helpful to subtype BBCL.
Journal ArticleDOI

Prognostic impact of karyotype and immunologic phenotype in 125 adult patients with de novo AML.

TL;DR: The expected correlations of rather immature myeloid immunologic phenotypes with M1 and M2 morphology and CD14 expression in monoblastic leukemias was found and remission rate and survival were significantly worse in 19 patients with complex nonrandom aberrations, where blast cell expression of blood group H antigen and of TdT were significantly increased.